skip to primary navigationskip to content
 

PolyProx Therapeutics raises £3.4m seed financing to validate novel class of cancer drugs

last modified May 01, 2019 08:22 AM
A spin out of the Department of Pharmacology at the University of Cambridge, PolyProx Therapeutics is based on over a decade of research and intellectual property from founder Professor Laura Itzhaki’s laboratory...

A spin out of the Department of Pharmacology at the University of Cambridge, PolyProx Therapeutics is based on over a decade of research and intellectual property from founder Professor Laura Itzhaki’s laboratory working closely with co-founders Dr Albert Perez-Riba and Dr Pamela Rowling and with other members of the Itzhaki group.

PolyProx Therapeutics will develop a new class of drugs, called Polyproxin™ molecules, that are able to selectively target tumour cells and trigger the natural degradation machinery contained within the cell to arrest tumour growth.

Polyproxin™ molecules target disease-causing proteins within tumour cells and trigger pathways to eliminate these proteins, thereby halting further growth of the tumour.  This approach has the potential to address cancer targets that have proven untreatable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers. The technology behind this approach uses protein scaffolds to link a targeting entity at one end and a degradation trigger at the other, assembled in such a way as to allow access to the tumour cell and recyclable activity.

More details: www.polyprox.com and https://www.cambridgenetwork.co.uk/news/polyprox-therapeutics-3pt4mgbp-seed-financing-cancer-drugs/

« July 2020 »
July
MoTuWeThFrSaSu
12345
6789101112
13141516171819
20212223242526
2728293031

RSS Feed Latest news

CONGRATULATIONS!

Jul 07, 2020

Ana Rossi and Janet Kumita

Transformation of naked mole-rat cells

Jul 01, 2020

Dr. Walid Khaled & Dr. Ewan Smith had a paper accepted in Nature that has been featured by the University and the Guardian...

Dr Graham Ladds

Jun 25, 2020

The Department is delighted to announce that Graham Ladds has been promoted to Reader...

Key cancer gene

Apr 14, 2020

Switching on a key cancer gene could provide first curative treatment for heart disease...

University Closure Due to Covid-19 Outbreak

Mar 19, 2020

The Department of Pharmacology will be closed from 5pm on Friday 20th March and until further notice.

View all news